Table 1 The expression of MTFR2 in Ualcan database was correlated to the clinicopathological characteristics in LUAD patients
Clinicopathological characteristics | p value |
|---|---|
Expression | |
 Normal-vs-Primary | 1.62447832963153E-12 |
Gender | |
 Male-vs-Female | 4.185800E-02 |
Age | |
 Age(41-60Yrs)-vs-Age(61-80Yrs) | 1.089890E-02 |
Smoking | |
 Non smoker-vs-Smoker | 7.3849000004067E-07 |
 Non smoker-vs-Reformed smoker2 | 6.560800E-03 |
 Smoker-vs-Reformed smoker1 | 1.53600000496468E-08 |
 Smoker-vs-Reformed smoker2 | 1.978210E-03 |
 Reformed smoker1-vs-Reformed smoker2 | 1.955780E-04 |
Cancer stages | |
 Stage1-vs-Stage2 | 4.427500E-02 |
Tissue types | |
 NOS-vs-Mixed | 2.900200E-02 |
 NOS-vs-LBC-Non Mucinous | 2.038200E-03 |
 NOS-vs-Solid Pattern Predominant | 2.599600E-02 |
 NOS-vs-Acinar | 5.378900E-03 |
 NOS-vs-LBC-Mucinous | 1.70860000003881E-06 |
 NOS-vs-Papillary | 1.027880E-04 |
 Mixed-vs-Solid Pattern Predominant | 1.196000E-02 |
 Mixed-vs-LBC-Mucinous | 4.00150000001709E-06 |
 Mixed-vs-Papillary | 4.149500E-02 |
 Clear Cell-vs-LBC-Non Mucinous | 4.028200E-02 |
 Clear Cell-vs-Papillary | 2.063500E-02 |
 LBC-Non Mucinous-vs-Solid Pattern Predominant | 4.452100E-02 |
 LBC-Non Mucinous-vs-LBC-Mucinous | 1.174210E-02 |
 Solid Pattern Predominant-vs-LBC-Mucinous | 1.926450E-02 |
 Solid Pattern Predominant-vs-Mucinous carcinoma | 4.480600E-03 |
 Solid Pattern Predominant-vs-Papillary | 3.801800E-02 |
 Acinar-vs-LBC-Mucinous | 1.693590E-02 |
 LBC-Mucinous-vs-Papillary | 1.804030E-02 |
TP53 Mutant | |
 TP53-Mutant-vs-TP53-Non Mutant | 1.81166193158333E-12 |